Small Pharma Inc.
DMTTFOTCHealthcare
$0.11
$-0.01(-9.69%)
Market Cap$37505507
P/E Ratio—
52W High$0.1905
52W Low$0.045
Small Pharma Inc. (DMTTF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
DMTTF · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2023Report Date: May 31, 2023EPS Actual
-$0.01
Revenue
—
Fiscal Period
Q2 FY2023
FY ends December
Report Date
May 31, 2023
After Market Close
✓ 1-Quarter EPS Beat Streak
DMTTF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q2 FY2023 | May 31, 2023 | — | -$0.01 | — | — | — | — |
| — Q2 FY2023 | May 31, 2023 | — | -$0.01 | — | — | — | — |
| — Q1 FY2023 | Feb 28, 2023 | — | -$0.01 | — | — | — | — |
| — Q1 FY2023 | Feb 28, 2023 | — | -$0.01 | — | — | — | — |
| — Q1 FY2023 | Jan 25, 2023 | -$0.02 | -$0.02 | +0.0% | — | — | — |
| — Q4 FY2022 | Nov 30, 2022 | — | -$0.02 | — | — | — | — |
| ▼ Q4 FY2022 | Oct 14, 2022 | -$0.02 | -$0.02 | -13.1% | — | — | — |
| — Q3 FY2022 | Aug 31, 2022 | — | -$0.02 | — | — | — | — |
Q2 FY2023
May 31, 2023
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2023
May 31, 2023
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2023
Feb 28, 2023
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2023
Feb 28, 2023
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2023
Jan 25, 2023
EPS Actual
-$0.02
EPS Est.
-$0.02
EPS Surpr.
+0.0%
Revenue
—
Q4 FY2022
Nov 30, 2022
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2022
Oct 14, 2022Miss
EPS Actual
-$0.02
EPS Est.
-$0.02
EPS Surpr.
-13.1%
Revenue
—
Q3 FY2022
Aug 31, 2022
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
—
No analyst estimates available for DMTTF.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2023 | May 31, 2023 | — | $0.05 | $0.05 | -0.78% |
| — Q2 FY2023 | May 31, 2023 | — | $0.05 | $0.05 | -0.78% |
| — Q1 FY2023 | Feb 28, 2023 | — | $0.08 | $0.07 | -9.87% |
| — Q1 FY2023 | Feb 28, 2023 | — | $0.08 | $0.07 | -9.87% |
| ▲ Q1 FY2023 | Jan 25, 2023 | +0.0% | $0.08 | $0.09 | +13.16% |
| — Q4 FY2022 | Nov 30, 2022 | — | $0.08 | $0.07 | -12.20% |
| ▼ Q4 FY2022 | Oct 14, 2022 | -13.1% | $0.11 | $0.12 | +9.12% |
| — Q3 FY2022 | Aug 31, 2022 | — | $0.18 | $0.24 | +31.95% |
Q2 FY2023-0.78%
Report Date
May 31, 2023
EPS Beat/Miss
—
Price Before
$0.05
Price After
$0.05
Q2 FY2023-0.78%
Report Date
May 31, 2023
EPS Beat/Miss
—
Price Before
$0.05
Price After
$0.05
Q1 FY2023-9.87%
Report Date
Feb 28, 2023
EPS Beat/Miss
—
Price Before
$0.08
Price After
$0.07
Q1 FY2023-9.87%
Report Date
Feb 28, 2023
EPS Beat/Miss
—
Price Before
$0.08
Price After
$0.07
Q1 FY2023+13.16%
Report Date
Jan 25, 2023
EPS Beat/Miss
+0.0%
Price Before
$0.08
Price After
$0.09
Q4 FY2022-12.20%
Report Date
Nov 30, 2022
EPS Beat/Miss
—
Price Before
$0.08
Price After
$0.07
Q4 FY2022+9.12%
Report Date
Oct 14, 2022
EPS Beat/Miss
-13.1%
Price Before
$0.11
Price After
$0.12
Q3 FY2022+31.95%
Report Date
Aug 31, 2022
EPS Beat/Miss
—
Price Before
$0.18
Price After
$0.24
Avg Beat Reaction+13.16%
Avg Miss Reaction+9.12%
Beat Rate1 / 8 quarters
Largest Move+31.95% (Q3 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: DMTTF ends December
Small Pharma Inc. (DMTTF) most recently reported earnings on May 31, 2023 for Q2 FY2023, posting EPS of $-0.01 (in line with the analyst consensus of —). The next DMTTF earnings date is expected around September 1, 2026.
Each quarter, investors track DMTTF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DMTTF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
DMTTF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
DMTTF earnings · 4 questionsSmall Pharma Inc.'s next earnings report is expected around September 1, 2026. DMTTF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DMTTF historically reports after market close (AMC).
DMTTF earnings datewhen is DMTTF earningsDMTTF next earnings datewhen does DMTTF report earningsDMTTF earnings calendar
▸ Source: FMP · Small Pharma Inc. SEC filings · US GAAP · Small Pharma Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026